We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Caldera is a heat battery company that seeks to institutionalise zero-carbon energy solutions for the masses. Its patented breakthrough, Warmstone heat battery, can store 100kWh of heat for a standard home for 24 hours. Caldera asserts that it takes renewable energy using a flexible green tariff with prices as low as 5p/kWh and stores it as heat, providing carbon-free hot water and heating via Warmstone. The company has raised over £1.5 million through grants and investment to date, installed its first pilot Warmstone product in a family home, established a manufacturing and R&D base, and acquired the support of an energy think tank, Energy Systems Catapult. It aspires to become a contender in the estimated £3.5 billion renewable energy storage market in the European Union (EU). The company is working with König Metall to build and sell Warmstone units via approved UK installers. Caldera will use the investment to install a small number of pilot units in trial homes in 2021 before a full commercial rollout in 2022.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,572,524
Perspective Pictures is a creative, digital-first video production company based in North London. The company asserts that existing video production companies produce good TV advertisements and long-form pieces for brands but fail to find an engaged online audience. PP asserts that its team of employees with an average age of 25, and in-house production crew and creatives allow it to produce a variety of video ads from a short snappy, subtitled Facebook ad to a long-form 22 minute YouTube series drawing in the target audience. The company sold over £200,000 worth of video content in the first 60 days of 2020. It has featured in news publications like The Evening Standard, Forbes, BA BusinessLife, Moneyweek, and Shortlist. PP will use the investment to make £2 million worth of video content per year, invest in team training and education to ensure that it can offer the best service/product to its clients, and help manage cash flow and unexpected situations.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £108,046
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £691,497
Feed is a platform that automates digital advertising for musicians and creators by enabling them to grow an audience and build their businesses. The creator needs to connect their social media accounts to the Feed portal and set a budget. The portal will then create ads that reach new people and convert engaged audiences into loyal fans over time. The company asserts that existing ad generation platforms are too complex, time-consuming and expensive for creators. Feed argues that its portal caters to a variety of budgets, requires no marketing knowledge and takes minutes to get started. The beta platform is integrated with Facebook's & Instagram's ad network and has 500 creators on board. The company will use the investment to launch the paid version of Feed in Q4 2020. 

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £146,117
planarTECH is an engineering company founded in 2014 as a provider of process equipment for the growth and characterisation of graphene and other emerging 2D materials. Its core product line is the planarGROW Chemical Vapor (CVD) system. The company has the ability to deliver scalable production systems that allow lower-cost production of graphene in comparison to other options currently available in the market. Moreover, from 2014 to 2019, the company’s cumulative revenues exceeded £5 million. The company's products have been installed and used by faculties and students at prestigious universities like Stanford University (USA), IIT- Bombay (India), Deakin University (Australia), and many others. From the investment, the company will utilise 45% as working capital, 30% in Capital Expenditures (CAPEX), 15% in R&D and 10% in hiring additional staff.

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £425,061
YurOn is a video platform that cultivates authentic interaction between prominent personalities and their fans. The portal allows people from different walks of life–drag queens, mountaineers, activists–thirty seconds to ignite a conversation, start an Ask Me Anything or co-create a skit. YurOn shuns away filters, anonymous commenting, vanity metrics or validation-driven algorithms and endeavours to bring to the public an unadulterated conversation between stars and their fans. The portal soft-launched in Q2 of 2020 and has seen over 5000 downloads, 2000 active users, and 32% of users retaining over a month. The company will use 80% of the investment to grow its tech team and cloud infrastructure, and 20% towards marketing and partnerships to accelerate growth.

Pitch Rated

46%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £222,110
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
SeedStream is a digital content platform that uses Artificial Intelligence (AI) to combine articles, videos and podcasts into personalised feeds based on user interests. The company has built a prototype focussing on Formula 1 motorsport that aggregates free-to-access news articles and YouTube videos alongside social media posts from the drivers and teams to cover stories from every angle. SeedStream aims to be a disruptor in the 580 million subscription services market. The company will use the investment to develop its prototype into a complete platform, produce original content based on trending topics, and accelerate into different markets.

Pitch Rated

44%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £40,843
Nikalyte is a specialist in nanoparticles research and development (R&D) as well as commercialisation in various application areas such as cell binding, cell separation, drug delivery, catalysis, nano-photonics, and electrochemistry. The company is developing a nanoparticle generator, which will enable researchers to produce nanoparticles of almost any metal or alloy on almost any substrate via a user-friendly interface. Nikalyte is offering free nanoparticle samples to researchers investigating antiviral materials, such as Copper and Silver, towards developing a vaccine for Covid-19. The company also offers a consultancy service that provides advice on nanoparticle applications and ultra-high vacuum systems. The company aims to use the investment to scale its business.

Pitch Rated

37%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
HighCandi is a drone services business that specialises in providing operational support to large companies, for example, in telecommunications and renewable energy sectors. It brings together independent drone service providers under one brand and uses these drones to inspect infrastructure, providing photo analysis, video inspections, and 3D digital models of facilities to help clients manage their assets in an affordable manner. HighCandi’s app, which can memorise and automate inspection regimes, makes sure that each drone delivers consistent imaging and data. The company's aerial videographers are Civil Aviation Authority (CAA) licensed and adhere to legal restrictions wherever they film. The company's strategy is to target 10% ($520 million) of two key sectors, namely The Global Industrial Inspection market and European Real Estate market, by 2021. HighCandi is a potential disruptor in the drone sector which is expected to boost the UK economy by £42 billion. With the investment, the company will start recruitment to drive sales, pilot engagement, and brand marketing.

Pitch Rated

36%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph